Press-release for stocks for beigene, ltd. for amgn

entities : Beigene, ltd. symbols : Amgn

save search

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published: 2024-03-09 (Crawled : 20:20) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K

n/a

| Email alert Add to watchlist
CCXI | News | $51.99 -0.04%

Health Technology

| Email alert Add to watchlist
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| Email alert Add to watchlist
otezla research

AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -12.87% | O: -0.93% H: 3.2% C: 2.66%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -1.1% | O: -0.1% H: 0.18% C: -1.25%

AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
Published: 2024-02-26 (Crawled : 14:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -10.39% | O: 2.6% H: 1.87% C: 0.7%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -5.41% | O: -0.31% H: 0.55% C: -0.66%

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
ZYME | $8.56 -1.72% -1.75% 490K

Health Technology

| -24.45% | O: 0.26% H: 2.42% C: 0.97%
NSTG M | $0.1053 -37.43% -0.19% 0

Health Technology

| 30.48% | O: -31.6% H: 410.14% C: 110.51%
BIIB | $193.18 -0.48% 5.8% 1.2M

Health Technology

| -19.69% | O: -0.27% H: 0.27% C: 0.17%
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -5.94% | O: -1.87% H: 0.61% C: -1.46%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -7.55% | O: 0.38% H: 0.34% C: -0.72%

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.99 -0.31% 0.41% 7.1M

Health Technology

| -0.55% | O: -0.14% H: 0.35% C: -1.12%
XNCR | $18.37 0.88% 0.76% 480K

Health Technology

| -3.87% | O: -0.05% H: 0.0% C: -2.09%
SNY | News | $47.69 1.15% 1.13% 1.6M

Health Technology

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -9.5% | O: -3.53% H: 1.53% C: -0.27%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
year financial results

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SWTX | $44.0 2.59% 2.43% 870K

Health Technology

| 15.91% | O: -1.58% H: 11.22% C: 11.16%
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -15.96% | O: 0.36% H: 3.65% C: 3.35%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -9.72% | O: -0.5% H: 3.18% C: 3.12%
conference therapeutics

AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)
Published: 2023-12-26 (Crawled : 14:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -21.08% | O: 0.36% H: 1.17% C: -0.59%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -3.74% | O: -0.01% H: 0.21% C: -0.08%
lumakras update

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published: 2023-12-13 (Crawled : 21:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -24.19% | O: 0.91% H: 2.03% C: 1.4%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -2.87% | O: -0.11% H: 0.5% C: -1.78%
fda lung review cancer cell application grants advanced

AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
Published: 2023-12-12 (Crawled : 21:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -22.6% | O: 0.25% H: 2.68% C: 1.83%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -0.16% | O: 0.06% H: 2.8% C: 2.72%
first

AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
Published: 2023-12-08 (Crawled : 14:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -22.51% | O: -1.32% H: 0.78% C: -1.13%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 0.82% | O: -0.05% H: 0.3% C: -0.76%

AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
Published: 2023-11-10 (Crawled : 14:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology

| -26.67% | O: 2.63% H: 2.5% C: 2.35%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 3.59% | O: 0.98% H: 0.49% C: 0.25%
research cardiovascular

AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published: 2023-11-07 (Crawled : 21:00) - prnewswire.com
BGNE | $138.99 6.15% 5.95% 120

Health Technology